CoQ10 has also been shown to help patients with chronic heart failure, improving symptoms and reducing major cardiovascular events. https://t.co/M6h9nszUTg
The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2020 – Aug 2025Where it's discussed
-
News26 articles
-
Facebook21 posts
-
X / Twitter18 posts
-
Blogs6 articles
-
YouTube2 videos
-
Reddit2 posts
-
Bluesky1 posts
AI synopsis
What people are saying
The overall tone demonstrates strong support for the study's findings, with users highlighting impressive statistics such as a 42.3% reduction in major cardiovascular events and mentioning the drug's potential to influence treatment standards. Words like 'proven,' 'effective,' and questions like 'why don't all doctors prescribe CoQ10' reflect high interest and a belief in its significance, indicating these discussions could impact future medical approaches.
Most discussions endorse the positive findings of the study, highlighting significant reductions in cardiovascular events and mortality, which shows general support for the results.
Many posts delve into detailed results, mentioning specific percentages and the potential of CoQ10 as an effective treatment, reflecting high curiosity and interest.
Conversations include references to scientific studies, comparisons, and questions about clinical practices, indicating deep involvement with the topic.
Posts suggest the study could influence medical practice and future research, emphasizing that CoQ10 might be undervalued or overlooked despite promising evidence.
Abstract in brief
- This study investigated whether adding coenzyme Q10 (CoQ10) to standard treatment helps people with chronic heart failure (HF).
- The results showed that long-term CoQ10 use reduced major heart-related problems and deaths, improved symptoms, and was safe over two years.
- However, short-term improvements were not significant, but patients taking CoQ10 had notably fewer hospital visits and lower rates of death from cardiovascular issues and overall causes.]
Top posts
Most liked on X and BlueskyHere is one for starters: - Major adverse cardiovascular events: 42.3% reduction (26% to 15%) - Cardiovascular mortality: 43.8% reduction (16% to 9%) - All-cause mortality: 44.4% reduction (18% to 10%). https://t.co/EYkBgrf3ra https://t.co/Q1madzyxzz
▶️ 慢性心不全とCoenzyme Q10について 二重盲検のランダム化比較試験 Fig2にサブグループ解析も載っていました _φ(・_・ The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart... https://t.co/u5ibYhy3eF
The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (2014) https://t.co/jiZHMNtXEu Patients with moderate to severe HF were randomly assigned in a 2-year prospective trial to either CoQ10 100 mg 3 times daily or placebo, in addition to standard therapy
@drjohnm Thanks for the RT! Time will tell; there are basic science links between ketones and cardiac fibrosis https://t.co/kiCXz7bozD ...and don't forget that the only proven metabolic treatment, Coenzyme-Q10, failed to enter mainstream despite a positive study https://t.co/QtWjMUx72u
@masonbrown1788 @mirandadevine Why don't all doctors prescribe CO-Q10 for heart failure? It is the most effective medication according to this trial https://t.co/ldQvv1xVWV
All mentions
Benefits of Coenzyme Q10 in Managing Chronic Heart Failure
This study explored the impact of adding Coenzyme Q10 to standard treatment for chronic heart failure, showing reduced heart-related problems, hospital visits, and mortality over two years.
Mitochondrial Health Supplements CoQ10 and PQQ Benefits
This series explains cardiovascular disease mechanisms and risk factors. Coenzyme Q10 and PQQ play vital roles in heart health, with evidence supporting their benefits in reducing cardiovascular issues, hospital visits…
RT @erlesen: The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (2014) https://t.co/jiZHMNtXEu Patients with mo…
RT @erlesen: The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (2014) https://t.co/jiZHMNtXEu Patients with mo…
The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (2014) www.sciencedirect.com/science/arti... Patients with moderate to severe HF were randomly assigned in a 2-year prospective trial to either CoQ10 100 mg 3 times daily or placebo, in addition to standard therapy
The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure (2014) https://t.co/jiZHMNtXEu Patients with moderate to severe HF were randomly assigned in a 2-year prospective trial to either CoQ10 100 mg 3 times daily or placebo, in addition to standard therapy
RT @gregmushen: Here is one for starters: - Major adverse cardiovascular events: 42.3% reduction (26% to 15%) - Cardiovascular mortality:…
Here is one for starters: - Major adverse cardiovascular events: 42.3% reduction (26% to 15%) - Cardiovascular mortality: 43.8% reduction (16% to 9%) - All-cause mortality: 44.4% reduction (18% to 10%). https://t.co/EYkBgrf3ra https://t.co/Q1madzyxzz
@drjohnm Thanks for the RT! Time will tell; there are basic science links between ketones and cardiac fibrosis https://t.co/kiCXz7bozD ...and don't forget that the only proven metabolic treatment, Coenzyme-Q10, failed to enter mainstream despite a positive study https://t.co/QtWjMUx72u
RT @KagawaECG: ▶️ 慢性心不全とCoenzyme Q10について 二重盲検のランダム化比較試験 Fig2にサブグループ解析も載っていました _φ(・_・ The Effect of Coenzyme Q10 on Morbidity and Mortali…
▶️ 慢性心不全とCoenzyme Q10について 二重盲検のランダム化比較試験 Fig2にサブグループ解析も載っていました _φ(・_・ The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart... https://t.co/u5ibYhy3eF
心不全患者のQ10摂取で、罹患率や死亡率が低下したとの報告 Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649.
RT @drkohilathas: CoQ10 has also been shown to help patients with chronic heart failure, improving symptoms and reducing major cardiovascul…
RT @drkohilathas: CoQ10 has also been shown to help patients with chronic heart failure, improving symptoms and reducing major cardiovascul…
RT @drkohilathas: CoQ10 has also been shown to help patients with chronic heart failure, improving symptoms and reducing major cardiovascul…
CoQ10 has also been shown to help patients with chronic heart failure, improving symptoms and reducing major cardiovascular events. https://t.co/M6h9nszUTg
CoQ10 - Essential cofactor for energy production - Treat heart conditions and heart failure - Key nutrient to mitochondria https://t.co/5w9IJdBUIE
RT @DennisZeilstra: @FaberDietetiek Tip: maak ook onderscheid tussen ubiquinon en ubiquinol. Laatstgenoemde is de gereduceerde vorm (en duu…
@FaberDietetiek Tip: maak ook onderscheid tussen ubiquinon en ubiquinol. Laatstgenoemde is de gereduceerde vorm (en duurder, maar lagere dosis volstaat). Ook interessant om ff te bekijken, de Q-Symbio studie, een relatief grote en lange studie bij hartfalen: https://t.co/A4iT6jdYxB
…. Y es que podemos ver beneficios demostrados sobre… 1 Problemas cardiovasculares https://t.co/lyZL4BQKBi
@masonbrown1788 @mirandadevine Why don't all doctors prescribe CO-Q10 for heart failure? It is the most effective medication according to this trial https://t.co/ldQvv1xVWV
LE
GM
K
R
WW
SU
DP
R
お
P
அ
DF
H
PV
DZ
PN